1. Home
  2. PDI vs RGEN Comparison

PDI vs RGEN Comparison

Compare PDI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Fund

PDI

PIMCO Dynamic Income Fund

HOLD

Current Price

$16.02

Market Cap

7.6B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$136.75

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDI
RGEN
Founded
N/A
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.6B
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
PDI
RGEN
Price
$16.02
$136.75
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$167.67
AVG Volume (30 Days)
2.3M
1.1M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
N/A
$14.30
Revenue Next Year
N/A
$14.52
P/E Ratio
N/A
$917.33
Revenue Growth
N/A
35.10
52 Week Low
$16.00
$100.99
52 Week High
$20.05
$175.77

Technical Indicators

Market Signals
Indicator
PDI
RGEN
Relative Strength Index (RSI) 34.74 57.39
Support Level $16.10 $139.40
Resistance Level $16.79 $149.98
Average True Range (ATR) 0.11 5.40
MACD -0.03 -0.90
Stochastic Oscillator 1.54 74.11

Price Performance

Historical Comparison
PDI
RGEN

About PDI PIMCO Dynamic Income Fund

PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: